Reverse Transcriptase Inhibitors

Reverse Transcriptase Inhibitors (RTIs) are drugs used to treat HIV/AIDS. They work by blocking the action of reverse transcriptase, an enzyme used by HIV to make copies of its genetic material. RTIs interrupt the reproduction process of HIV, preventing the virus from infecting more cells. They are a mainstay of HIV therapy, used in combination with other antiretroviral drugs for long-term control of the virus. RTIs are also used to treat other viral infections, such as hepatitis B and C. These drugs offer a powerful control of viral replication and are an essential part of modern drug regimens.

← Journal of Current Viruses and Treatment Methodologies

Related Articles

6 article(s) found

A Rare Cause of Fever of Unknown Origin: Reverse Shapiro’s Syndrome

Full-text HTML Download PDF Download XML

Docking Studies of HIV-1 Reverse Transcriptase and HIV-1 Protease with Phytocompounds of Carissa Carandas L.

Full-text HTML Download PDF Download XML

Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Induce Aging by Inhibiting Telomerase Function

Full-text HTML Download PDF Download XML

Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish Embryo during Organogenesis and their Role as Epigenetics Regulators able to Reverse Neurosensory Hearing Loss

Full-text HTML Download PDF Download XML

Cross-Reactivity between COX-2 Inhibitors in Patients with Cross-Reactive Hypersensitivity to NSAIDs

Full-text HTML Download PDF Download XML

Natural Polyphenols as Inhibitors for the Binding of Covid-19 S-RBD with ACE-2

Full-text HTML Download PDF Download XML